Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
(Source: Trials)
Source: Trials - February 15, 2022 Category: Research Source Type: clinical trials
Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
Condition: Recurrent Pregnancy Loss Intervention: Drug: Hydroxychloroquine Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2022 Category: Research Source Type: clinical trials